Shares of Danaher Corp. DHR slipped 8.15% to $181.77 Friday, on what proved to be an all-around poor trading session for the ...

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 ...

Danaher Corporation DHR has been benefiting from solid momentum in its clinical diagnostics business, driven by growth in the ...

Danaher Corp. closed 29.75% below its 52-week high of $281.70, which the company achieved on August 1st.

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

Danaher Corporation incorporates science and technology and has a market cap of $150B. Click here to read why I rate DHR ...

Out of all of the options we uncovered, 15 are puts, for a total amount of $1,238,077, and there was 1 call, for a total ...

Discover why Danaher Corporation's 5-year low presents a potential growth opportunity. Explore its strong fundamentals & ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Danaher (DHR – Research Report) on April 1 and set a price target of $270.00. The ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other big-cap stocks that are plunging so far in 2025. The market has been reversing its gains ...

In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...

We recently published a list of Top 10 Stocks to Buy According to Akre Capital Management. In this article, we are going to ...